Letermovir (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Letermovir" in Hungarian language version.

refsWebsite

Global rank Hungarian rank

5doi.org

2^nd place

8^th place

4europa.eu

68^th place

37^th place

4nih.gov

4^th place

11^th place

2worldcat.org

5^th place

22^nd place

1deutsche-apotheker-zeitung.de

low place

1clinicalleader.com

low place

1onclive.com

low place

1sagepub.com

731^st place

2,041^st place

1dovepress.com

low place

1wiley.com

222^nd place

312^th place

clinicalleader.com

Masangkay: Merck Kicks Off Phase 3 Study Of CMV Drug Letermovir, 2014. július 29. (Hozzáférés: 2014. október 8.)

deutsche-apotheker-zeitung.de

„Neues Virostatikum Letermovir”, Deutsche Apothekerzeitung, 2011. augusztus 29. (german nyelvű)

doi.org

dx.doi.org

(2019. június 4.) „Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review”. Infection and Drug Resistance 12, 1481–1491. o. DOI:10.2147/IDR.S180908. PMID 31239725. PMC 6556539.
Shigle, Terri Lynn, Roy F. (2020. január 1.). „Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant” (angol nyelven). Therapeutic Advances in Hematology 11, 204062072093715. o. DOI:10.1177/2040620720937150. ISSN 2040-6207. PMID 32637057.
(2019. június 4.) „Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review”. Infection and Drug Resistance 12, 1481–1491. o. DOI:10.2147/IDR.S180908. PMID 31239725.
Helou, Guy El: Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review (english nyelven). Infection and Drug Resistance, 2019. június 4. DOI:10.2147/idr.s180908. (Hozzáférés: 2021. július 8.)
Lin, Andrew, Yiqi (2019. január 30.). „Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience” (angol nyelven). Transplant Infectious Disease 21 (6), e13187. o. DOI:10.1111/tid.13187. ISSN 1399-3062.

dovepress.com

Helou, Guy El: Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review (english nyelven). Infection and Drug Resistance, 2019. június 4. DOI:10.2147/idr.s180908. (Hozzáférés: 2021. július 8.)

europa.eu

ema.europa.eu

Prevymis: EPAR – Product Information. European Medicines Agency, 2021. február 1.
Prevymis
Prevymis: EPAR – Product Information. European Medicines Agency, 2021. február 1.
Prevymis: EPAR – Public assessment report. European Medicines Agency, 2018. január 17.

nih.gov

pubmed.ncbi.nlm.nih.gov

(2019. június 4.) „Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review”. Infection and Drug Resistance 12, 1481–1491. o. DOI:10.2147/IDR.S180908. PMID 31239725. PMC 6556539.
Shigle, Terri Lynn, Roy F. (2020. január 1.). „Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant” (angol nyelven). Therapeutic Advances in Hematology 11, 204062072093715. o. DOI:10.1177/2040620720937150. ISSN 2040-6207. PMID 32637057.
(2019. június 4.) „Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review”. Infection and Drug Resistance 12, 1481–1491. o. DOI:10.2147/IDR.S180908. PMID 31239725.

ncbi.nlm.nih.gov

(2019. június 4.) „Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review”. Infection and Drug Resistance 12, 1481–1491. o. DOI:10.2147/IDR.S180908. PMID 31239725. PMC 6556539.

onclive.com

„FDA Approves Letermovir for CMV Prophylaxis Post-Transplantation”, onclive.com, 2017. november 9.

sagepub.com

journals.sagepub.com

Shigle, Terri Lynn, Roy F. (2020. január 1.). „Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant” (angol nyelven). Therapeutic Advances in Hematology 11, 204062072093715. o. DOI:10.1177/2040620720937150. ISSN 2040-6207. PMID 32637057.

wiley.com

onlinelibrary.wiley.com

Lin, Andrew, Yiqi (2019. január 30.). „Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience” (angol nyelven). Transplant Infectious Disease 21 (6), e13187. o. DOI:10.1111/tid.13187. ISSN 1399-3062.

worldcat.org

Shigle, Terri Lynn, Roy F. (2020. január 1.). „Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant” (angol nyelven). Therapeutic Advances in Hematology 11, 204062072093715. o. DOI:10.1177/2040620720937150. ISSN 2040-6207. PMID 32637057.
Lin, Andrew, Yiqi (2019. január 30.). „Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience” (angol nyelven). Transplant Infectious Disease 21 (6), e13187. o. DOI:10.1111/tid.13187. ISSN 1399-3062.